Search by Drug Name or NDC

    NDC 00093-0314-01 Ketorolac Tromethamine 10 mg/1 Details

    Ketorolac Tromethamine 10 mg/1

    Ketorolac Tromethamine is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is KETOROLAC TROMETHAMINE.

    Product Information

    NDC 00093-0314
    Product ID 0093-0314_453df394-038f-40aa-af05-1d99fa5a5dd5
    Associated GPIs 66100037100320
    GCN Sequence Number 016404
    GCN Sequence Number Description ketorolac tromethamine TABLET 10 MG ORAL
    HIC3 S2B
    HIC3 Description NSAIDS, CYCLOOXYGENASE INHIBITOR TYPE ANALGESICS
    GCN 32531
    HICL Sequence Number 005175
    HICL Sequence Number Description KETOROLAC TROMETHAMINE
    Brand/Generic Generic
    Proprietary Name Ketorolac Tromethamine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ketorolac Tromethamine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name KETOROLAC TROMETHAMINE
    Labeler Name Teva Pharmaceuticals USA, Inc.
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA074754
    Listing Certified Through 2024-12-31

    Package

    NDC 00093-0314-01 (00093031401)

    NDC Package Code 0093-0314-01
    Billing NDC 00093031401
    Package 100 TABLET, FILM COATED in 1 BOTTLE (0093-0314-01)
    Marketing Start Date 1998-06-17
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.51301
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description KETOROLAC 10 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis